Aifen Lin

3.3k total citations
93 papers, 2.5k citations indexed

About

Aifen Lin is a scholar working on Immunology, Reproductive Medicine and Agronomy and Crop Science. According to data from OpenAlex, Aifen Lin has authored 93 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 24 papers in Reproductive Medicine and 20 papers in Agronomy and Crop Science. Recurrent topics in Aifen Lin's work include Reproductive System and Pregnancy (53 papers), Reproductive Physiology in Livestock (20 papers) and Endometriosis Research and Treatment (19 papers). Aifen Lin is often cited by papers focused on Reproductive System and Pregnancy (53 papers), Reproductive Physiology in Livestock (20 papers) and Endometriosis Research and Treatment (19 papers). Aifen Lin collaborates with scholars based in China, United States and South Africa. Aifen Lin's co-authors include Wei‐Hua Yan, Dan‐Ping Xu, Huihui Xu, Heping Xu, Yanyun Ruan, J.‐G. Zhang, Xia Zhang, Min Zhu, Wenjun Zhou and Mengya Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Aifen Lin

90 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aifen Lin China 33 1.8k 601 469 432 398 93 2.5k
Diana Prus Israel 19 1.7k 0.9× 739 1.2× 529 1.1× 370 0.9× 420 1.1× 54 2.7k
M. Garcia-Lloret United States 15 788 0.4× 119 0.2× 230 0.5× 67 0.2× 230 0.6× 25 1.3k
Arend Mulder Netherlands 38 3.3k 1.8× 96 0.2× 275 0.6× 1.1k 2.4× 613 1.5× 129 5.0k
Lennart Kjellberg Sweden 17 528 0.3× 88 0.1× 141 0.3× 168 0.4× 386 1.0× 24 1.3k
Lewis Perrin Australia 25 198 0.1× 893 1.5× 235 0.5× 305 0.7× 375 0.9× 77 2.0k
Neil T. Young United Kingdom 20 3.0k 1.7× 57 0.1× 78 0.2× 589 1.4× 195 0.5× 51 3.4k
Michael A. Steller United States 22 360 0.2× 160 0.3× 210 0.4× 238 0.6× 277 0.7× 36 1.2k
Isabelle Fayt Belgium 18 340 0.2× 637 1.1× 125 0.3× 217 0.5× 149 0.4× 50 1.3k
Tadao K. Kobayashi Japan 23 140 0.1× 266 0.4× 222 0.5× 221 0.5× 164 0.4× 148 1.6k
Salim E. Kabawat United States 9 354 0.2× 574 1.0× 119 0.3× 167 0.4× 192 0.5× 10 1.1k

Countries citing papers authored by Aifen Lin

Since Specialization
Citations

This map shows the geographic impact of Aifen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aifen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aifen Lin more than expected).

Fields of papers citing papers by Aifen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aifen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aifen Lin. The network helps show where Aifen Lin may publish in the future.

Co-authorship network of co-authors of Aifen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Aifen Lin. A scholar is included among the top collaborators of Aifen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aifen Lin. Aifen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chih‐Ying, Chih‐Chuang Liaw, Yuying Wu, et al.. (2025). Ugonin P mitigates osteolytic bone metastasis by suppressing MDK via upregulating miR-223-3p expression. International Journal of Biological Sciences. 21(8). 3740–3754.
2.
Lin, Aifen, Adam J. Lamble, Rhonda E. Ries, et al.. (2025). TP53 inactivation confers resistance to the menin inhibitor revumenib in Acute Myeloid Leukemia. Blood. 146(Supplement 1). 3470–3470.
3.
Qi, Lisha, Xiaoli Li, Yong Yang, et al.. (2024). Accuracy of machine learning in the preoperative identification of ovarian borderline tumors: a meta-analysis. Clinical Radiology. 79(7). 501–514. 1 indexed citations
4.
Han, Qiu-Yue, Xia Zhang, Jiangang Zhang, et al.. (2022). Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer. International Immunopharmacology. 113(Pt A). 109371–109371. 13 indexed citations
5.
Chen, Yuxin, Qiu-Yue Han, Wenjun Zhou, et al.. (2021). Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer. Frontiers in Immunology. 12. 679090–679090. 30 indexed citations
6.
Zhang, Ruili, et al.. (2019). Expression and clinical significance of sHLA-G in plasma exosome in patients with colorectal cancer. Zhonghua jianyan yixue zazhi. 42(5). 347–353. 3 indexed citations
7.
Lin, Aifen, et al.. (2019). Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients. Frontiers in Oncology. 9. 28–28. 8 indexed citations
8.
Zhang, Xia, et al.. (2018). Biobanking of Fresh-Frozen Gastric Cancer Tissues: Impact of Long-Term Storage and Clinicopathological Variables on RNA Quality. Biopreservation and Biobanking. 17(1). 58–63. 16 indexed citations
9.
Zhu, Yimin, Hanlin Lu, Dandan Zhang, et al.. (2018). Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. Clinical Epigenetics. 10(1). 30–30. 33 indexed citations
10.
Lin, Aifen, Xia Zhang, Ruili Zhang, et al.. (2018). Clinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients. Frontiers in Oncology. 8. 361–361. 21 indexed citations
11.
Ruan, Yanyun, et al.. (2016). Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer. Human Immunology. 77(4). 317–324. 24 indexed citations
12.
Zhang, Xia, Jiangang Zhang, Wenjun Zhou, et al.. (2012). Biobanking of Fresh-frozen Human Colon Tissues: Impact of Tissue Ex-vivo Ischemia Times and Storage Periods on RNA Quality. Annals of Surgical Oncology. 20(5). 1737–1744. 57 indexed citations
13.
Lin, Aifen, Huihui Xu, Dan‐Ping Xu, et al.. (2012). Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression. Human Immunology. 74(4). 439–446. 45 indexed citations
14.
Xu, Dan‐Ping, et al.. (2011). Elevation of plasma soluble human leukocyte antigen–G in patients with chronic hepatitis C virus infection. Human Immunology. 72(5). 406–411. 38 indexed citations
15.
Zhang, Bo, et al.. (2010). Expression and Its Clinical Significance of eIF4E in Non-small Cell Lung Cancer. SHILAP Revista de lepidopterología. 5 indexed citations
16.
Gan, Lixia, et al.. (2010). Polymorphism of human CD1a, CD1d, and CD1e in exon 2 in Chinese Han and She ethnic populations. Tissue Antigens. 75(6). 691–695. 8 indexed citations
17.
Lin, Aifen, Chengsong Zhu, J.‐G. Zhang, et al.. (2009). Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancer. Journal of Cellular and Molecular Medicine. 14(9). 2318–2329. 57 indexed citations
18.
Lin, Aifen, et al.. (2009). Aberrant human leucocyte antigen‐G expression and its clinical relevance in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 14(8). 2162–2171. 77 indexed citations
19.
Yan, Wei‐Hua, et al.. (2007). Possible Roles of KIR2DL4 Expression on uNK Cells in Human Pregnancy. American Journal of Reproductive Immunology. 57(4). 233–242. 50 indexed citations
20.
Lin, Aifen, Wei‐Hua Yan, Heping Xu, et al.. (2007). HLA-G expression in human ovarian carcinoma counteracts NK cell function. Annals of Oncology. 18(11). 1804–1809. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026